登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式(希尔记法):
C16H16O9 · xH2O
化学文摘社编号:
分子量:
352.29 (anhydrous basis)
NACRES:
NA.52
PubChem Substance ID:
UNSPSC Code:
12352200
MDL number:
grade
Molecular Biology
Quality Level
product line
BioReagent
assay
≥98% (HPLC)
form
powder
solubility
pyridine: 50 mg/mL, clear, colorless to very faintly yellow
storage temp.
−20°C
SMILES string
O.CC1=CC(=O)Oc2cc(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)ccc12
InChI
1S/C16H16O9.H2O/c1-6-4-10(17)24-9-5-7(2-3-8(6)9)23-16-13(20)11(18)12(19)14(25-16)15(21)22;/h2-5,11-14,16,18-20H,1H3,(H,21,22);1H2/t11-,12-,13+,14-,16+;/m0./s1
InChI key
URVSQZMOFUEQAW-YYHOVTOASA-N
General description
MUG是一种常用于检测转化植物的化学品。 在用转化植物中编码的葡萄糖醛酸酶(GUS)处理之前,MUG显示低水平的荧光。 可以通过转化植物的MUG荧光对其进行鉴定。
Application
适用于对植物中葡萄糖醛酸酶基因的表达进行荧光检测。
Preparation Note
产品可以0.35 mg/ml的浓度溶于分子生物级水中。
Still not finding the right product?
Explore all of our products under 4-甲基伞形基β-D-葡糖苷酸 水合物
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
商品
Probiotics exhibit an inhibitory effect on pathogens, help prevent chronic intestinal inflammatory diseases or atopic syndromes, and support the immune system.
相关内容
Product Information Sheet
L J Moberg
Applied and environmental microbiology, 50(6), 1383-1387 (1985-12-01)
An assay procedure to screen for Escherichia coli in foods by using 4-methylumbelliferyl-beta-D-glucuronide (MUG) incorporated into lauryl tryptose (LST) broth was evaluated. The beta-glucuronidase produced by E. coli cleaves the MUG substrate to yield a fluorescent end product. E. coli-negative
Andrew G Kunihiro et al.
Molecular nutrition & food research, 64(14), e2000072-e2000072 (2020-06-09)
Curcumin prevents bone loss in resorptive bone diseases and inhibits osteoclast formation, a key process driving bone loss. Curcumin circulates as an inactive glucuronide that can be deconjugated in situ by bone's high β-glucuronidase (GUSB) content, forming the active aglycone.
Helena C Besse et al.
Pharmaceutics, 12(6) (2020-06-14)
The poor pharmacokinetics and selectivity of low-molecular-weight anticancer drugs contribute to the relatively low effectiveness of chemotherapy treatments. To improve the pharmacokinetics and selectivity of these treatments, the combination of a doxorubicin-glucuronide prodrug (DOX-propGA3) nanogel formulation and the liberation of
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| M9130-1G | 04061835516643 |
| M9130-100MG | 04061835574360 |
| M9130-250MG | 04061834063933 |
| M9130-25MG | 04061834063940 |